Miglitol

In the US, Miglitol (miglitol systemic) is a member of the drug class alpha-glucosidase inhibitors and is used to treat Diabetes, Type 2.

US matches:

• Miglitol

Scheme

Prop.INN

ATC (Anatomical Therapeutic Chemical Classification)

A10BF02

CAS registry number (Chemical Abstracts Service)

0072432-03-2

Chemical Formula

C8-H17-N-O5

Molecular Weight

207

Therapeutic Category

Oral antidiabetic agent, α-glucosidase inhibitor

Chemical Name

3,4,5-Piperidinetriol, 1-(2-hydroxyethyl)-2-(hydroxymethyl)-, [2R-(2α,3ß,4α,5ß)]-

Foreign Names

• Miglitolum (Latin)
• Miglitol (German)
• Miglitol (French)
• Miglitol (Spanish)

Generic Names

• Miglitol (OS: BAN, USAN)
• Bay m 1099 (IS: Bayer)

Brand Names

• Diastabol
  Sanofi-Aventis, Austria; Sanofi-Aventis, Switzerland; Sanofi-Aventis, Germany; Sanofi-Aventis, France; Sanofi-Aventis, Hungary; Sanofi-Aventis, Mexico; Sanofi-Aventis, Poland; Sanofi-Aventis, Slovakia; Sanofi-Aventis S.A., Spain; Sanofi-Synthelabo, Greece



• Euglitol
  Nicholas, India



• Glycet
  Pfizer, United States



• Plumarol
  Lacer, Spain



• Seibule
  Sanwa Kagaku, Japan

International Drug Name Search

Glossary

BAN	British Approved Name
IS	Inofficial Synonym
OS	Official Synonym
Prop.INN	Proposed International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.